These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10611726)

  • 41. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel.
    Martin DF; Dunn JP; Davis JL; Duker JS; Engstrom RE; Friedberg DN; Jaffe GJ; Kuppermann BD; Polis MA; Whitley RJ; Wolitz RA; Benson CA
    Am J Ophthalmol; 1999 Mar; 127(3):329-39. PubMed ID: 10088745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraocular HIV-1-specific IgG synthesis in a patient with CMV retinitis.
    Dix RD; Resnick L; Culbertson W; Dickinson G; Fisher E; Saenz M
    Reg Immunol; 1989; 2(1):1-6. PubMed ID: 2561959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy.
    Di Perri G; Vento S; Mazzi R; Bonora S; Bonora A; Trevenzoli M; Allegranzi B; Carretta G; Lanzafame M; Pizzighella S; Concia E
    J Infect; 1999 Nov; 39(3):193-7. PubMed ID: 10714794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Heinemann MH
    Am J Med; 1992 Feb; 92(2A):12S-16S. PubMed ID: 1310570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS.
    Dalessandro L; Bottaro E
    Scand J Infect Dis; 2002; 34(10):780-2. PubMed ID: 12477338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in the therapy and prevention of CMV infections.
    Nichols WG; Boeckh M
    J Clin Virol; 2000 Feb; 16(1):25-40. PubMed ID: 10680738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.
    Peters BS; Beck EJ; Anderson S; Coleman D; Coker R; Main J; Migdal C; Harris JR; Pinching AJ
    J Infect; 1991 Sep; 23(2):129-37. PubMed ID: 1661316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Spector SA
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):9-12, 15-22. PubMed ID: 11363539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of cytomegalovirus infection in patients with acquired immunodeficiency syndrome.
    Pau AK; Pitrak DL
    Clin Pharm; 1990 Aug; 9(8):613-31. PubMed ID: 2167189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis.
    Ussery FM; Gibson SR; Conklin RH; Piot DF; Stool EW; Conklin AJ
    Ophthalmology; 1988 May; 95(5):640-8. PubMed ID: 2845321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changing therapeutic paradigms in CMV retinitis in AIDS.
    Piper H; Ciulla TA; Danis RP; Pratt LM
    Expert Opin Pharmacother; 2000 Dec; 1(7):1343-52. PubMed ID: 11249469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic options for resistant cytomegalovirus retinitis.
    Kuppermann BD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local therapy for cytomegalovirus retinitis.
    Smith CL
    Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
    Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
    Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CMV encephalitis during ganciclovir therapy of CMV retinitis.
    Schwarz TF; Loeschke K; Hanus I; Jäger G; Feiden W; Stefani FH
    Infection; 1990; 18(5):289-90. PubMed ID: 2177454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
    ;
    N Engl J Med; 1992 Jan; 326(4):213-20. PubMed ID: 1345799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.